Inflexion takes minority stake in European LifeCare Group

The investment was made through Inflexion Enterprise Fund IV, which closed on £250m in May 2016. The fund makes equity investments of between £10-35m. 

ELCG will use the additional capital to pursue a rapid buy-and-build strategy, aiming to double their number of clinics in conjunction with Inflexion.

A post from early September on the ELCG website states that the offer price was DKK 5.5m per share.

The group is understood to have established an English holding company to facilitate the investment.

Company
Founded in 1998, ELCG provides vaccines to public health systems, including the Danish and English national health services, private individuals, and businesses.  

The group's 2017 annual report stated revenues for the calendar year were DKK 119.42m, with gross profit of DKK 58.82m, and DKK 15.29m in operating profit. ELCG's website reports DKK 38.2m revenues and DKK 5.2m EBITDA in Q1 2018.

People
Inflexion Private Equity – Simon Turner (managing partner); Tim Smallbone (partner); Ben Long (investment director); Richard Wootten, Robin Senivassen (assistant directors).
European LifeCare Group – Karsten Ostergaard (CEO, co-founder); Kristian Tuft (CFO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Healthcare
• Nordics
• Minority investing
• Inflexion Private Equity
• United Kingdom